Literature DB >> 21725561

PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.

Catia Morelli1, Pamela Maris, Diego Sisci, Enrico Perrotta, Elvira Brunelli, Ida Perrotta, Maria Luisa Panno, Antonio Tagarelli, Carlo Versace, Maria Francesca Casula, Flaviano Testa, Sebastiano Andò, Janos B Nagy, Luigi Pasqua.   

Abstract

Mesoporous silica nanoparticles (MSNs) have been proposed as DNA and drug delivery carriers, as well as efficient tools for fluorescent cell tracking. The major limitation is that MSNs enter cells regardless of a target-specific functionalization. Here we show that non functionalized MSNs, synthesized using a PEG surfactant-based interfacial synthesis procedure, do not enter cells, while a highly specific, receptor mediated, cellular internalization of folic acid (FOL) grafted MSNs (MSN-FOL), occurs exclusively in folate receptor (FR) expressing cells. Neither the classical clathrin pathway nor macropinocytosis is involved in the MSN endocytic process, while fluorescent MSNs (MSN-FITC) enter cells through aspecific, caveolae-mediated, endocytosis. Moreover, internalized particles seem to be mostly exocytosed from cells within 96 h. Finally, cisplatin (Cp) loaded MSN-FOL were tested on cancerous FR-positive (HeLa) or normal FR-negative (HEK293) cells. A strong growth arrest was observed only in HeLa cells treated with MSN-FOL-Cp. The results presented here show that our mesoporous nanoparticles do not enter cells unless opportunely functionalized, suggesting that they could represent a promising vehicle for drug targeting applications. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725561     DOI: 10.1039/c1nr10253b

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  19 in total

Review 1.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

2.  Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica Nanoparticles.

Authors:  William A Walker; Mubin Tarannum; Juan L Vivero-Escoto
Journal:  J Mater Chem B       Date:  2016-01-07       Impact factor: 6.331

3.  Pegylated siRNA-loaded calcium phosphate nanoparticle-driven amplification of cancer cell internalization in vivo.

Authors:  Lisa A Tobin; Yili Xie; Maria Tsokos; Su I Chung; Allison A Merz; Michael A Arnold; Guang Li; Harry L Malech; King F Kwong
Journal:  Biomaterials       Date:  2013-01-29       Impact factor: 12.479

4.  Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.

Authors:  Guilan Quan; Xin Pan; Zhouhua Wang; Qiaoli Wu; Ge Li; Linghui Dian; Bao Chen; Chuanbin Wu
Journal:  J Nanobiotechnology       Date:  2015-02-03       Impact factor: 10.435

Review 5.  Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.

Authors:  Domenico Lombardo; Pietro Calandra; Davide Barreca; Salvatore Magazù; Mikhail A Kiselev
Journal:  Nanomaterials (Basel)       Date:  2016-06-25       Impact factor: 5.076

6.  Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications.

Authors:  Wei Liu; Arnaud Chaix; Magali Gary-Bobo; Bernard Angeletti; Armand Masion; Afitz Da Silva; Morgane Daurat; Laure Lichon; Marcel Garcia; Alain Morère; Khaled El Cheikh; Jean-Olivier Durand; Frédérique Cunin; Mélanie Auffan
Journal:  Nanomaterials (Basel)       Date:  2017-09-23       Impact factor: 5.076

Review 7.  Dealing with Skin and Blood-Brain Barriers: The Unconventional Challenges of Mesoporous Silica Nanoparticles.

Authors:  Alessandra Nigro; Michele Pellegrino; Marianna Greco; Alessandra Comandè; Diego Sisci; Luigi Pasqua; Antonella Leggio; Catia Morelli
Journal:  Pharmaceutics       Date:  2018-12-01       Impact factor: 6.321

8.  Engineering Tumor-Targeting Nanoparticles as Vehicles for Precision Nanomedicine.

Authors:  Amber Gonda; Nanxia Zhao; Jay V Shah; Hannah R Calvelli; Harini Kantamneni; Nicola L Francis; Vidya Ganapathy
Journal:  Med One       Date:  2019-09-30

Review 9.  Mesoporous silica nanoparticles for drug and gene delivery.

Authors:  Yixian Zhou; Guilan Quan; Qiaoli Wu; Xiaoxu Zhang; Boyi Niu; Biyuan Wu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2018-02-12       Impact factor: 11.413

Review 10.  Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review.

Authors:  Nadda Muhamad; Tullayakorn Plengsuriyakarn; Kesara Na-Bangchang
Journal:  Int J Nanomedicine       Date:  2018-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.